COVID-19
These findings may well change how future screening for COVID-19 infections is conducted. Excerpt from the article: “The study results suggest that radiologists must keep in mind that patients with COVID-19 can initially present with symptoms other than respiratory ones but still have the disease, wrote a team led by Dr. Rydhwana Hossain of the University…
Read More
Gladstone President Emeritus Sandy Williams explains how Gladstone scientists are leveraging their existing research to address the COVID-19 pandemic. Continue Reading The Article
Read More
The world has been greatly impacted by the COVID-19 pandemic and many are waiting in much anticipation for a vaccine and treatments. Many researchers are working tirelessly on COVID-19 research efforts and we have seen many institutions receive funding to support research studies. Join us for an evening of discussion on the important research efforts…
Read More
Excerpt from the press release: Osaka, JAPAN, and King of Prussia, PA, USA – 7 May 2020 – The CoVIg-19 Plasma Alliance, an unprecedented plasma industry collaboration recently established to accelerate the development of a plasma-derived hyperimmune globulin therapy for COVID-19, is rapidly building momentum. Its membership has expanded globally to include 10 plasma companies, and…
Read More
Veristat has published an interesting overview of the EMA guidance: Summary of Key Considerations Outlined in the Third Edition of the EMA Guidance “The European Medicines Agency (EMA) has now published its third version of the Guidance on the Management of Clinical Trials during the COVID-19 (Coronavirus) Pandemic. This guidance addresses the need for sponsors…
Read More
Excerpt from the announcement: TORONTO, ON — May 14, 2020 – The Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit organization dedicated to advancing health technology innovation and commercialization, announced today a Canada-wide call for applications from companies for its Early Adopter Health Network (EAHN™) to address COVID-19. Click the button below to read the article:…
Read More
Excerpt from the article: “As SARS-CoV-2, the deadly coronavirus responsible for COVID-19, spread from Wuhan, China, to nearly every country around the globe, dozens of companies rushed to develop a vaccine against the novel virus. The Coalition for Epidemic Preparedness Innovations (CEPI), a leading global funder of vaccine development, put its vote of confidence in…
Read More
Excerpt from the announcement: “The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is urgently soliciting proposals and can provide up to $500M across multiple projects to rapidly produce innovative SARS-CoV-2 diagnostic tests that will assist the public’s safe return to normal activities. Rapid Acceleration of Diagnostics (RADx), is a fast-track technology development program that…
Read More
GIOSTAR Announces FDA Approval Under Compassionate Use for a COVID-19 Clinical Trial with Stem Cells
Excerpt from the press release: SAN DIEGO, May 4, 2020 /PRNewswire/ — Global Institute of Stem Cell Therapy and Research (GIOSTAR), the worldwide leader in stem cell research, is pleased to announce that they have received an approval for a COVID-19 clinical trial, led by their Medical Director Dr. Prabhat Soni. GIOSTAR will conduct the…
Read More
Excerpt from the article: “There is no denying that the COVID-19 pandemic has spurred tremendous innovation across our industry. Even more impressive is the pace at which we have been able to implement technology solutions that can facilitate continued progress in our critical activities and trials. Most importantly, the expansion of telemedicine and virtual solutions…
Read More